The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(2-Oxohexadecanamido)propanoic acid ID: ALA3769469
Chembl Id: CHEMBL3769469
PubChem CID: 127025412
Max Phase: Preclinical
Molecular Formula: C19H35NO4
Molecular Weight: 341.49
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCCCCCCCC(=O)C(=O)N[C@@H](C)C(=O)O
Standard InChI: InChI=1S/C19H35NO4/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-17(21)18(22)20-16(2)19(23)24/h16H,3-15H2,1-2H3,(H,20,22)(H,23,24)/t16-/m0/s1
Standard InChI Key: LOAOKESTGXTVSA-INIZCTEOSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 341.49Molecular Weight (Monoisotopic): 341.2566AlogP: 4.24#Rotatable Bonds: 16Polar Surface Area: 83.47Molecular Species: ACIDHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.77CX Basic pKa: ┄CX LogP: 5.56CX LogD: 2.29Aromatic Rings: ┄Heavy Atoms: 24QED Weighted: 0.32Np Likeness Score: 0.07
References 1. Vasilakaki S, Barbayianni E, Leonis G, Papadopoulos MG, Mavromoustakos T, Gelb MH, Kokotos G.. (2016) Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulations., 24 (8): [PMID:26970660 ] [10.1016/j.bmc.2016.02.040 ]